Xiufang Chen
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Chen et al. Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2. Antioxidants 2024, 13, 400.
Journal: Antioxidants (Basel, Switzerland)
Published: December 19, 2025
FOXO1-driven endothelial senescence in bicuspid aortic valve-associated thoracic aortic aneurysm.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 05, 2025
Modeling Thoracic Aortic Dissection Using Patient-Specific iPSCs Reveals VSMC Dysfunction and Extracellular Matrix Dysregulation.
Journal: Stem cells international
Published: December 31, 2024
Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2.
Journal: Antioxidants (Basel, Switzerland)
Published: March 03, 2024
Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.
Journal: Cell death & disease
Published: December 05, 2021
Puerarin Increases Survival and Protects Against Organ Injury by Suppressing NF-κB/JNK Signaling in Experimental Sepsis.
Journal: Frontiers in pharmacology
Published: February 29, 2020
Glutathione prevents chronic oscillating glucose intake-induced β-cell dedifferentiation and failure.
Journal: Cell death & disease
Published: February 05, 2019
Correction: Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1.
Journal: Cell death & disease
Published: July 18, 2018
S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation.
Journal: EBioMedicine
Published: July 11, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026